This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DEH vs. APT, MLSS, LGMK, CVAC, TRVI, DVAX, ESTA, CALT, PHVS, and SYREShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Alpha Pro Tech (APT), Milestone Scientific (MLSS), LogicMark (LGMK), CureVac (CVAC), Trevi Therapeutics (TRVI), Dynavax Technologies (DVAX), Establishment Labs (ESTA), Calliditas Therapeutics AB (publ) (CALT), Pharvaris (PHVS), and Spyre Therapeutics (SYRE). D8 vs. Its Competitors Alpha Pro Tech Milestone Scientific LogicMark CureVac Trevi Therapeutics Dynavax Technologies Establishment Labs Calliditas Therapeutics AB (publ) Pharvaris Spyre Therapeutics Alpha Pro Tech (NYSE:APT) and D8 (NYSE:DEH) are both small-cap surgical appliances & supplies industry companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings. Does the media refer more to APT or DEH? In the previous week, Alpha Pro Tech's average media sentiment score of 1.95 beat D8's score of -0.73 indicating that Alpha Pro Tech is being referred to more favorably in the media. Company Overall Sentiment Alpha Pro Tech Very Positive D8 Negative Which has stronger valuation and earnings, APT or DEH? Alpha Pro Tech has higher revenue and earnings than D8. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Pro Tech$58.56M0.84$4.19M$0.3413.78D8N/AN/A-$9.46MN/AN/A Is APT or DEH more profitable? Alpha Pro Tech has a net margin of 6.99% compared to D8's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat D8's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Pro Tech6.99% 6.70% 5.76% D8 N/A N/A N/A Do insiders and institutionals hold more shares of APT or DEH? 22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 65.4% of D8 shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryAlpha Pro Tech beats D8 on 7 of the 8 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DEH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$244.95M$25.12M$6.05B$21.48BDividend YieldN/AN/A5.73%3.67%P/E RatioN/A12.7084.8129.66Price / SalesN/A1.90602.5786.18Price / CashN/A12.8025.7717.79Price / Book47.331.9312.554.63Net Income-$9.46M-$5.31M$3.32B$1.01B D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$5.68-2.7%N/A-8.9%$244.95MN/A0.003APTAlpha Pro Tech2.4207 of 5 stars$4.80+0.2%N/A-18.3%$50.27M$58.56M12.97120MLSSMilestone Scientific2.4607 of 5 stars$0.56+17.5%$1.25+124.8%-38.1%$44.39M$9.08M-8.0730News CoverageGap UpLGMKLogicMark0.16 of 5 stars$0.00-3.0%N/A-99.8%$1.84M$9.88M0.0020CVACCureVac3.7396 of 5 stars$5.42-0.1%$6.83+26.2%+85.2%$1.21B$579.18M5.64880TRVITrevi Therapeutics2.5462 of 5 stars$9.96+1.4%$21.75+118.4%+211.2%$1.21BN/A-23.6520Gap DownDVAXDynavax Technologies4.4892 of 5 stars$10.28+0.9%$24.33+136.8%-4.0%$1.20B$316.27M-22.34350ESTAEstablishment Labs2.7482 of 5 stars$41.28+2.9%$56.50+36.9%+3.3%$1.20B$166.02M-13.551,018Positive NewsAnalyst DowngradeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180PHVSPharvaris2.4753 of 5 stars$22.75-1.0%$32.60+43.3%+11.9%$1.19BN/A-6.7730SYRESpyre Therapeutics2.943 of 5 stars$19.92+12.6%$54.29+172.6%-34.1%$1.18B$890K-5.7773News CoverageAnalyst Upgrade Related Companies and Tools Related Companies APT Competitors MLSS Competitors LGMK Competitors CVAC Competitors TRVI Competitors DVAX Competitors ESTA Competitors CALT Competitors PHVS Competitors SYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DEH) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
